Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Arch. Soc. Esp. Oftalmol ; 96(5): 265-269, mayo 2021. ilus, tab
Artigo em Espanhol | IBECS | ID: ibc-217827

RESUMO

Mujer de 32 años con antecedente de miomatosis uterina y metrorragias a repetición durante seis meses que condicionan una concentración de hemoglobina de 6,5 g/dL con requerimiento de transfusión de eritrocitos. Presentó una hora postransfusión, pérdida visual súbita e indolora del ojo derecho (OD) sin otra sintomatología, siendo remitida al departamento de Neuro-oftalmología. Al ingreso su agudeza visual corregida fue movimiento de manos en OD y 0,6 en el izquierdo (OI). El segmento anterior fue normal, salvo un defecto pupilar aferente relativo en OD. Funduscópicamente el OD resaltó una retina pálida difusa con mancha rojo cereza, compatible con oclusión de la arteria central de la retina, OI normal. Se intentó manejo sin mejoría. Los estudios oculares corroboraron isquemia retiniana en OD. Durante la evaluación sistémica los estudios de neuroimágenes, paneles autoinmunes y hematológicos fueron negativos, por lo que se atribuyó dicha complicación a la transfusión de glóbulos rojos (AU)


A 32-year-old woman presented with a history of uterine myomatosis and repeated bleeding for 6 months. This produced a haemoglobin concentration of 6.5 g/dL, with a requirement for a red blood cell transfusion. One hour after the transfusion, she presented with a sudden and painless loss of vision in the right eye (RE). As she had no other symptoms, she was referred to the Neuro-Ophthalmology Department. On admission, her corrected visual acuity was hand movement in RE, and 0.6 in the left eye (LE). The anterior segment was unremarkable, except for a relative afferent pupillary defect in RE. In the fundus examination, the RE showed a diffuse pale retina with a cherry spot, consistent with occlusion of the central artery of the retina. Management was attempted but with no improvement. The studies corroborated retinal ischaemia in RE. During the systemic evaluation, the neuroimaging, autoimmune and haematology studies were negative, thus this complication was attributed to the red blood cell transfusion (AU)


Assuntos
Humanos , Feminino , Adulto , Oclusão da Artéria Retiniana/diagnóstico por imagem , Oclusão da Artéria Retiniana/etiologia , Transfusão de Eritrócitos/efeitos adversos
2.
Arch Soc Esp Oftalmol (Engl Ed) ; 96(5): 265-269, 2021 May.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-32660764

RESUMO

A 32-year-old woman presented with a history of uterine myomatosis and repeated bleeding for 6 months. This produced a haemoglobin concentration of 6.5 g/dL, with a requirement for a red blood cell transfusion. One hour after the transfusion, she presented with a sudden and painless loss of vision in the right eye (RE). As she had no other symptoms, she was referred to the Neuro-Ophthalmology Department. On admission, her corrected visual acuity was hand movement in RE, and 0.6 in the left eye (LE). The anterior segment was unremarkable, except for a relative afferent pupillary defect in RE. In the fundus examination, the RE showed a diffuse pale retina with a cherry spot, consistent with occlusion of the central artery of the retina. Management was attempted but with no improvement. The studies corroborated retinal ischaemia in RE. During the systemic evaluation, the neuroimaging, autoimmune and haematology studies were negative, thus this complication was attributed to the red blood cell transfusion.

3.
Arch Soc Esp Oftalmol (Engl Ed) ; 94(6): 304-308, 2019 Jun.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-30502969

RESUMO

A 44 year-old Caucasian male with a history of plaque psoriasis currently being treated with ustekinumab presented with sudden loss of vision in his left eye. Fundus examination showed central retinal vein occlusion coexisting with central retinal artery occlusion. Posterior examination revealed mild polycythemia, being the underlying cause unknown.


Assuntos
Psoríase/complicações , Oclusão da Artéria Retiniana/etiologia , Oclusão da Veia Retiniana/etiologia , Adulto , Fármacos Dermatológicos/uso terapêutico , Humanos , Masculino , Psoríase/tratamento farmacológico , Oclusão da Artéria Retiniana/complicações , Oclusão da Veia Retiniana/complicações , Ustekinumab/uso terapêutico
4.
Rev. cuba. oftalmol ; 31(1): 72-81, ene.-mar. 2018.
Artigo em Espanhol | LILACS | ID: biblio-960632

RESUMO

La oclusión de la arteria central de la retina es considerada una urgencia oftalmológica con mal pronóstico visual, a pesar de los métodos convencionales de tratamiento. Los recientes avances en neurorradiología permiten realizar un cateterismo selectivo en la arteria oftálmica e inyectar un agente fibrinolítico cerca del lugar de la obstrucción. Esta intervención podría ser efectiva en ciertos tipos de oclusiones y se han obtenido resultados prometedores en pacientes con oclusiones de la arteria central de la retina. Se realizaron búsquedas en diferentes publicaciones relacionadas con la especialidad en los últimos 10 años en bases de datos de revistas líderes de Oftalmología, con el objetivo de mostrar la trombolisis intrarterial como opción de tratamiento para la oclusión de la arteria central de la retina. La baja incidencia de esta enfermedad, además de que los pacientes acuden a consulta con frecuencia fuera del periodo de ventana, son justificantes por las que no se recogen respuestas definitivas, lo que se suma a la heterogenicidad de tratamiento coadyuvante empleado en los diferentes centros y al uso de fibrinolíticos y de dosis variados. Se requieren ensayos clínicos aleatorizados que permitan determinar su superioridad frente a las medidas convencionales, el grado de beneficio en contraposición al riesgo de eventos adversos y el tipo de pacientes que son candidatos a esta medida terapéutica que se avecina de manera prometedora para mejorar el pronóstico visual de estos pacientes(AU)


The occlusion of the retina central artery is considered an ophthalmological emergency with poor visual prognosis, despite conventional treatment methods. Recent advances in neuroradiology allow a selective catheterization in the ophthalmic artery and inject a fibrinolytic agent near the site of the obstruction. This intervention could be effective in certain types of occlusions and promising results have been obtained in patients with Central Retina Artery occlusions. We searched different publications related to the specialty, using the database of leading journals of ophthalmology, in the last 10 years; with the objective of showing intra-arterial thrombolysis as an option of treatment for the Retinal Central Artery Occlusion. The low incidence of this disease, together with the fact that patients frequently visit outside the window period, are justifying why no definitive answers are collected, which adds to the heterogeneity of coadjutant treatment used in the different centers, controversial window period and use of fibrinolytics and varied doses. Randomized clinical trials are required to determine its superiority to conventional measures, the degree of benefit as opposed to the risk of adverse events and the type of patients that are candidates for this therapeutic approach that is promising to improve the visual prognosis of these patients(AU)


Assuntos
Humanos , Oclusão da Artéria Retiniana/terapia , Terapia Trombolítica/métodos , Bases de Dados Bibliográficas/estatística & dados numéricos , Estudo de Validação
5.
Rev. cuba. oftalmol ; 31(1): 72-81, ene.-mar. 2018.
Artigo em Espanhol | CUMED | ID: cum-73349

RESUMO

La oclusión de la arteria central de la retina es considerada una urgencia oftalmológica con mal pronóstico visual, a pesar de los métodos convencionales de tratamiento. Los recientes avances en neurorradiología permiten realizar un cateterismo selectivo en la arteria oftálmica e inyectar un agente fibrinolítico cerca del lugar de la obstrucción. Esta intervención podría ser efectiva en ciertos tipos de oclusiones y se han obtenido resultados prometedores en pacientes con oclusiones de la arteria central de la retina. Se realizaron búsquedas en diferentes publicaciones relacionadas con la especialidad en los últimos 10 años en bases de datos de revistas líderes de Oftalmología, con el objetivo de mostrar la trombolisis intrarterial como opción de tratamiento para la oclusión de la arteria central de la retina. La baja incidencia de esta enfermedad, además de que los pacientes acuden a consulta con frecuencia fuera del periodo de ventana, son justificantes por las que no se recogen respuestas definitivas, lo que se suma a la heterogenicidad de tratamiento coadyuvante empleado en los diferentes centros y al uso de fibrinolíticos y de dosis variados. Se requieren ensayos clínicos aleatorizados que permitan determinar su superioridad frente a las medidas convencionales, el grado de beneficio en contraposición al riesgo de eventos adversos y el tipo de pacientes que son candidatos a esta medida terapéutica que se avecina de manera prometedora para mejorar el pronóstico visual de estos pacientes(AU)


The occlusion of the retina central artery is considered an ophthalmological emergency with poor visual prognosis, despite conventional treatment methods. Recent advances in neuroradiology allow a selective catheterization in the ophthalmic artery and inject a fibrinolytic agent near the site of the obstruction. This intervention could be effective in certain types of occlusions and promising results have been obtained in patients with Central Retina Artery occlusions. We searched different publications related to the specialty, using the database of leading journals of ophthalmology, in the last 10 years; with the objective of showing intra-arterial thrombolysis as an option of treatment for the Retinal Central Artery Occlusion. The low incidence of this disease, together with the fact that patients frequently visit outside the window period, are justifying why no definitive answers are collected, which adds to the heterogeneity of coadjutant treatment used in the different centers, controversial window period and use of fibrinolytics and varied doses. Randomized clinical trials are required to determine its superiority to conventional measures, the degree of benefit as opposed to the risk of adverse events and the type of patients that are candidates for this therapeutic approach that is promising to improve the visual prognosis of these patients(AU)


Assuntos
Humanos , Oclusão da Artéria Retiniana/terapia , Terapia Trombolítica/métodos , Bases de Dados Bibliográficas , Estudo de Validação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...